Skip to content
10-Q

Quarterly Report

ANGIOTECH PHARMACEUTICALS INC

0001104659-12-077956

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 14, 2012 12.55M sh
Shares Diluted Q3 2012 · Sep 30, 2012 12.82M sh
Shares Diluted Q3 2012 · Sep 30, 2012 12.82M sh
Shares Diluted Q3 2012 · Sep 30, 2011 12.72M sh
Shares Diluted Q3 2012 · Sep 30, 2011 12.71M sh
Capex Q3 2012 · Sep 30, 2012 $447K
Capex Q3 2012 · Sep 30, 2012 $1.3M
Capex Q3 2012 · Sep 30, 2011 $349K
Capex Q3 2012 · Sep 30, 2011 $734K
Long Term Debt Q3 2012 · Sep 30, 2012 $289.41M
Long Term Debt Q3 2012 · Dec 31, 2011 $325M
Short Term Debt Q3 2012 · Sep 30, 2012 $40M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $59.71M
Cash And Equivalents Q3 2012 · Jun 30, 2012 $57.99M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $22.17M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $19.25M
Cash And Equivalents Q3 2012 · Jun 30, 2011 $21.64M
Cash And Equivalents Q3 2012 · Apr 30, 2011 $30.22M
Stockholders Equity Q3 2012 · Sep 30, 2012 $136.87M
Stockholders Equity Q3 2012 · Jun 30, 2012 $143.62M
Stockholders Equity Q3 2012 · Mar 31, 2012 $148.45M
Stockholders Equity Q3 2012 · Dec 31, 2011 $146.41M
Stockholders Equity Q3 2012 · Sep 30, 2011 $168.81M
Stockholders Equity Q3 2012 · Jun 30, 2011 $187.68M
Stockholders Equity Q3 2012 · May 2, 2011 $202.95M
Current Liabilities Q3 2012 · Sep 30, 2012 $82.39M
Current Liabilities Q3 2012 · Dec 31, 2011 $34.55M
Current Assets Q3 2012 · Sep 30, 2012 $144.33M
Current Assets Q3 2012 · Dec 31, 2011 $96.6M
Total Assets Q3 2012 · Sep 30, 2012 $626.84M
Total Assets Q3 2012 · Dec 31, 2011 $608.11M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.67
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.90
Eps Diluted Q3 2012 · Sep 30, 2011 −1.47
Eps Diluted Q3 2012 · Sep 30, 2011 −2.59
Eps Basic Q3 2012 · Sep 30, 2012 −$0.67
Eps Basic Q3 2012 · Sep 30, 2012 −$0.90
Eps Basic Q3 2012 · Sep 30, 2011 −$1.47
Eps Basic Q3 2012 · Sep 30, 2011 −$2.59
Sga Expense Q3 2012 · Sep 30, 2012 $16.01M
Sga Expense Q3 2012 · Sep 30, 2012 $51.44M
Sga Expense Q3 2012 · Sep 30, 2011 $22.61M
Sga Expense Q3 2012 · Sep 30, 2011 $35.39M
Sga Expense Q3 2012 · Sep 30, 2011 $0
Rd Expense Q3 2012 · Sep 30, 2012 $1.4M
Rd Expense Q3 2012 · Sep 30, 2012 $5.81M
Rd Expense Q3 2012 · Sep 30, 2011 $4.61M
Rd Expense Q3 2012 · Sep 30, 2011 $7.44M
Rd Expense Q3 2012 · Sep 30, 2011 $0
Operating Income Q3 2012 · Sep 30, 2012 $6.61M
Operating Income Q3 2012 · Sep 30, 2012 $18.17M
Operating Income Q3 2012 · Sep 30, 2011 −$18.07M
Operating Income Q3 2012 · Sep 30, 2011 −$29.38M
Operating Income Q3 2012 · Sep 30, 2011 $0
Gross Profit Q3 2012 · Sep 30, 2012 $32.47M
Gross Profit Q3 2012 · Sep 30, 2012 $102.18M
Gross Profit Q3 2012 · Sep 30, 2011 $18.55M
Gross Profit Q3 2012 · Sep 30, 2011 $28.54M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $24.07M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $76.08M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $38.8M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $65.73M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $0
Revenue Q3 2012 · Sep 30, 2012 $56.64M
Revenue Q3 2012 · Sep 30, 2012 $178.53M
Revenue Q3 2012 · Sep 30, 2011 $57.4M
Revenue Q3 2012 · Sep 30, 2011 $94.37M
Revenue Q3 2012 · Sep 30, 2011 $0